Wu E - Search Results

1

The economic burden of bipolar I disorder in the United States in 2015.

Cloutier M, Greene M, Guerin A, Touya M, Wu E. Cloutier M, et al. Among authors: wu e. J Affect Disord. 2018 Jan 15;226:45-51. doi: 10.1016/j.jad.2017.09.011. Epub 2017 Sep 14. J Affect Disord. 2018. PMID: 28961441 Free article.

2

Employees with overactive bladder: work loss burden.

Wu EQ, Birnbaum H, Marynchenko M, Mareva M, Williamson T, Mallett D. Wu EQ, et al. J Occup Environ Med. 2005 May;47(5):439-46. doi: 10.1097/01.jom.0000161744.21780.c1. J Occup Environ Med. 2005. PMID: 15891521

3

The economic burden of schizophrenia in the United States in 2002.

Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J. Wu EQ, et al. J Clin Psychiatry. 2005 Sep;66(9):1122-9. doi: 10.4088/jcp.v66n0906. J Clin Psychiatry. 2005. PMID: 16187769

4

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D. Wu EQ, et al. J Manag Care Pharm. 2007 Sep;13(7):561-9. doi: 10.18553/jmcp.2007.13.7.561. J Manag Care Pharm. 2007. PMID: 17874862 Free PMC article.

5

Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs.

Wu EQ, Greenberg PE, Yang E, Yu AP, Ben-Hamadi R, Erder MH. Wu EQ, et al. J Med Econ. 2009 Jun;12(2):124-35. doi: 10.3111/13696990903093537. J Med Econ. 2009. PMID: 19566483 Free article.

6

Economic burden of psoriasis compared to the general population and stratified by disease severity.

Yu AP, Tang J, Xie J, Wu EQ, Gupta SR, Bao Y, Mulani PM. Yu AP, et al. Curr Med Res Opin. 2009 Oct;25(10):2429-38. doi: 10.1185/03007990903185557. Curr Med Res Opin. 2009. PMID: 19663687

7

High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practice.

Saurat JH, Guérin A, Yu AP, Latremouille-Viau D, Wu EQ, Gupta SR, Bao Y, Mulani PM. Saurat JH, et al. Dermatology. 2010;220(2):128-37. doi: 10.1159/000275198. Epub 2010 Feb 3. Dermatology. 2010. PMID: 20130383 Free article.

8

Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension.

Signorovitch J, Zhang J, Wu EQ, Latremouille-Viau D, Yu AP, Dastani HB, Kahler KH. Signorovitch J, et al. Among authors: wu eq. Curr Med Res Opin. 2010 Apr;26(4):849-60. doi: 10.1185/03007991003613910. Curr Med Res Opin. 2010. PMID: 20141381

9

Economic burden of comorbidities in patients with psoriasis is substantial.

Kimball AB, Guérin A, Tsaneva M, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani PM. Kimball AB, et al. Among authors: wu eq. J Eur Acad Dermatol Venereol. 2011 Feb;25(2):157-63. doi: 10.1111/j.1468-3083.2010.03730.x. Epub 2010 Jun 17. J Eur Acad Dermatol Venereol. 2011. PMID: 20561129

10

Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study.

Yu AP, Xie J, Bensimon A, Parikh K, Wu EQ, Ben-Hamadi R, Blum S, Haim Erder M. Yu AP, et al. J Med Econ. 2010;13(4):599-609. doi: 10.3111/13696998.2010.521736. Epub 2010 Sep 29. J Med Econ. 2010. PMID: 20879834 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,572 results

Search Page

Filters